about
Mutational analysis of human hydroxysteroid sulfotransferase SULT2B1 isoforms reveals that exon 1B of the SULT2B1 gene produces cholesterol sulfotransferase, whereas exon 1A yields pregnenolone sulfotransferaseThe Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological DiseasesRegulation of the cytosolic sulfotransferases by nuclear receptorsInhibitory effects of kynurenic acid, a tryptophan metabolite, and its derivatives on cytosolic sulfotransferasesAndrogen deprivation by activating the liver X receptor.The dimerization motif of cytosolic sulfotransferases.How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR).Crystal structure-based studies of cytosolic sulfotransferase.Metabolic conversion as a pre-receptor control mechanism for lipophilic hormones.Sp1 elements in SULT2B1b promoter and 5'-untranslated region of mRNA: Sp1/Sp2 induction and augmentation by histone deacetylase inhibition.Enzymatic aspects of the phenol (aryl) sulfotransferases.Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways.Genetic profiling of colon cancer.Biomonitoring of arylamines and nitroarenes.Sulfation through the looking glass--recent advances in sulfotransferase research for the curious.Pharmacogenetics of the major polymorphic metabolizing enzymes.Human pharmacogenomic variations and their implications for antifungal efficacy.Cholesterol sulfate in human physiology: what's it all about?Sulfonation in pharmacology and toxicology.Cytochrome P450 humanised mice.Cytosolic sulfotransferase 2B1b promotes hepatocyte proliferation gene expression in vivo and in vitro.Human sulfotransferases and their role in chemical metabolism.Effects of dietary isoflavones from Puerariae radix on lipid and bone metabolism in ovariectomized ratsRegulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs.Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.Nutritional essentiality of sulfur in health and disease.Portable sulphotransferase domain determines sequence specificity of heparan sulphate 3-O-sulphotransferases.Mechanism of sulfotransferase pharmacogenetics in altered xenobiotic metabolism.Oxysterols are substrates for cholesterol sulfotransferase.Action of Halowax 1051 on Enzymes of Phase I (CYP1A1) and Phase II (SULT1A and COMT) Metabolism in the Pig Ovary.Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity.Phase II in vitro metabolism of 3-methylindole metabolites in porcine liver.LXR and PPAR activators stimulate cholesterol sulfotransferase type 2 isoform 1b in human keratinocytes.An investigation into the inter-relationships of sulphur xeno-biotransformation pathways in Parkinson's and motor neurone diseases.Influenza A virus infection activates cholesterol sulfotransferase (SULT2B1b) in the lung of female C57BL/6 mice.The essentiality of sulfur is closely related to nitrogen metabolism: a clue to hyperhomocysteinaemia.Expression of a skin cholesterol sulfotransferase, St2b2, is a trigger of epidermal cell differentiation.Tissue distribution and ontogeny of sulfotransferase enzymes in mice.Role for enhanced faecal excretion of bile acid in hydroxysteroid sulfotransferase-mediated protection against lithocholic acid-induced liver toxicity.
P2860
Q24302353-147E4C88-38E7-4B03-BE68-A43C18F571F3Q26765913-46D9C092-7273-4912-9A6B-A997407EC78FQ26997383-9B578026-7BA1-495A-9233-3EE6046D2040Q28115744-EE59F86E-9947-4589-B93D-EF961F9C8C67Q30439040-817C0209-69DC-47DE-AD29-F3645C03FA8FQ30979229-BC1E260A-4E69-4B00-972B-FECA0F0B0EE7Q34093093-11576362-4359-41CB-A10C-26FB6A59368CQ34161577-01C321A8-BAD1-407C-A8F8-F417EFB1ECADQ34205759-52704934-F497-4E2F-92AD-0CAA8DFFCC64Q34328117-C71537F8-59E4-423B-9E43-BB1F88D906EFQ34426136-EFC05072-92A4-49D4-B493-ED1117CB8189Q34479020-9CBBFB93-5DEA-450D-964C-48AC400345ACQ34496694-B0DEABE2-8264-4A80-A96B-EB8630B2E5F3Q34810958-5F215CFC-E2C2-441D-B9EF-32E2B22D0F8FQ35001236-58CCCAD4-2F8B-4FBA-9712-323BCC8B261EQ35002556-4E5D48E1-CD00-4EDB-AAEC-61FA08C2E9E1Q35067187-4716E24F-CD06-456C-AFCE-F98369B88E2AQ35070838-C82CDA6F-A937-4884-9E76-0EE612CBC904Q35120993-14C3E438-26B8-406E-BA1C-62045D4FB34BQ35956228-9D221D16-6C8B-40BB-8960-B49BB422A368Q35978586-B42303D6-4057-4E70-96A9-4EB44954B3E9Q36175918-11D8EDE2-E711-4E3E-9564-912582DAC4A1Q36328535-93274958-065E-465A-A71C-EC058DD373A7Q37083830-66C0CAA4-E7D3-4D67-B6A8-95BD8E312C3AQ37299710-90B041B2-642A-40FC-B117-3A272035C6B1Q38048826-3171469B-4B22-44A1-9C48-3667F594CCFFQ38118338-72F6A905-E00C-4B1D-8AEC-39DBB8976359Q38296721-539117FC-1861-4B79-A807-FF0FC0CFB96DQ38527536-FFFD73A7-4BE0-4D2D-AD19-5CF9B460DB06Q40161538-9706EF81-254D-47BB-B9C7-1F26E7641258Q40194075-4FA91594-F3D3-4ED2-A09C-FFA2FF807A90Q42438300-CB43C673-5A6D-4AF8-9957-D092F200E309Q44440348-40593B4A-FCF8-49C4-B082-7B9978233EFBQ44531983-B8B28529-F1B4-4897-9C93-31F1575F004DQ44759772-34F98CBE-4F26-42CE-B6D9-11759D28C147Q45363837-F290A607-80F8-4E6C-8C16-1FBDEE2021E9Q46199961-489265DA-C496-4973-96D6-7564BA2330BEQ46268415-07200F66-2522-424C-A927-DCFA84E1C9BDQ48484144-B723560C-AB32-4CF4-AC1E-86C71EAAC4D1Q51794207-9EDEDC58-8D96-4AEC-827F-D12F7C47EF9B
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pharmacogenetics of sulfotransferase.
@ast
Pharmacogenetics of sulfotransferase.
@en
type
label
Pharmacogenetics of sulfotransferase.
@ast
Pharmacogenetics of sulfotransferase.
@en
prefLabel
Pharmacogenetics of sulfotransferase.
@ast
Pharmacogenetics of sulfotransferase.
@en
P1476
Pharmacogenetics of sulfotransferase.
@en
P2093
P304
P356
10.1146/ANNUREV.PHARMTOX.40.1.159
P577
2000-01-01T00:00:00Z